Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Remtec Search

The specialist European Medical Device and Life Science recruitment company, working internationally to assist candidates and clients from across the world. Remtec offers 2 main services: Executive search and Contingency selection focusing on sales, marketing and technical roles. Our extensive experience, combined with proven processes, allows us to offer an unprecedented service to employers seeking top quality candidates and to candidates seeking top quality employers.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

Digital communications, Medical education, Recruitment and career development

Company Details

Remtec Search
Remtec Search and Selection Ltd, Registered Office, Breaks House, Mill Court, Cambridge, CB22 5LD, United Kingdom
+44 (0)1223 550 860
Contact Remtec Search
Website

 Latest Content from PMHub 

Developing Innovative Digital Strategies to Engage Patients

Videos and Podcasts | January 21, 2022 | Impetus Digital

Caitlin Wagner, Associate Marketing Director at Pharming, shares her expertise on innovative patient engagement strategies, including the roles of mobile apps and social media, the impact of the COVID-19 pandemic...

Cervical Cancer Prevention Month

White Papers and Resources | January 20, 2022 | Innovative Trials

In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer

6 critical success factors for flawless execution of a rapid first commercial launch

White Papers and Resources | January 19, 2022 | Avalere Health

Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline.

Meet Innovative Trials at SCOPE 2022

Press Releases | January 18, 2022 | Innovative Trials

Stop by Booth 1015 to meet the Innovative Trials' team during SCOPE 2022

We let your whole self shine

Videos and Podcasts | January 18, 2022 | Lucid Group Communications Limited

People are at the heart of who we are. Our aim is to transform the lives of those we touch without prejudice or discrimination. At Lucid, the magic we create...

Hybrid working: Insights and tips for success

White Papers and Resources | January 18, 2022 | Porterhouse Medical Group

Porterhouse Medical has thrived by embracing a hybrid approach to work. Our article looks at hybrid working and provides some tips for success

The New Normal: Upcoming Trends in Clinical Trials

Videos and Podcasts | January 13, 2022 | Impetus Digital

Samuel Searcy, Founder & CEO of CliniStart, shares his expert insights into trends, current gaps, and future predictions for clinical trials. Among many other things, we also dive into his...

The doctor will text you now: Why healthcare providers cannot underestimate the importance of communicating change

White Papers and Resources | January 12, 2022 | Say Communications

Healthcare communication needs to switch from ‘transmit’ to ‘receive’, listening to what patients need and embracing the plethora of communication tools wholeheartedly.

How to innovate and influence people in times of misinformation

White Papers and Resources | January 11, 2022 | Avalere Health

The pandemic has shown that public trust in promising new medical technologies is far from a given. Senior Writer Tom Vandyck at StoneArch, a member of Fishawack delves into the...

Ten unbeatable reasons to explore a career with Oxford PharmaGenesis in 2022

Press Releases | January 11, 2022 | Oxford PharmaGenesis

It’s a new year, and a time when many people reflect on whether their role is providing the opportunities, enjoyment and sense of purpose that they deserve. If this sounds...